Literature DB >> 3501740

Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis.

L Rombo, Y Bergqvist, U Hellgren.   

Abstract

The concentrations of chloroquine and desethylchloroquine in the blood of 10 healthy adult Swedish volunteers who had been taking 310 mg chloroquine base once a week for at least 8 months for malaria prophylaxis were measured. Samples of capillary whole blood from the volunteers were dried on filter-paper and the drug and its principal metabolite determined by a specific high-performance liquid chromatography (HPLC) method. The day after taking the drug, the mean concentration of chloroquine and desethylchloroquine in whole blood were 1305 nmol/l and 915 nmol/l, respectively, and immediately before the next weekly dose, 489 nmol/l and 384 nmol/l, respectively. These are considered to be greater than the minimum inhibitory concentrations for susceptible strains but less than the maximum tolerated concentrations. The dosage of chloroquine recommended roughly 40 years ago for regular long-term prophylaxis should therefore not be changed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501740      PMCID: PMC2491078     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications.

Authors:  J Brohult; L Rombo; V Sirleaf; E Bengtsson
Journal:  Ann Trop Med Parasitol       Date:  1979-10

2.  Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection.

Authors:  L C Patchen; D L Mount; I K Schwartz; F C Churchill
Journal:  J Chromatogr       Date:  1983-11-11

3.  Chloroquine-resistant falciparum malaria in Madagascar and Kenya.

Authors:  B Aronsson; E Bengtsson; A Björkman; P O Pehrson; L Rombo; M Wahlgren
Journal:  Ann Trop Med Parasitol       Date:  1981-08

4.  Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum.

Authors:  L Rombo; C M Kihamia; L F Mahikwano; O Ericsson; F Sjöqvist
Journal:  Trop Med Parasitol       Date:  1986-09

5.  On the question of dose-dependent chloroquine elimination of a single oral dose.

Authors:  L L Gustafsson; L Rombo; G Alván; A Björkman; M Lind; O Walker
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

6.  Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.

Authors:  Y Bergqvist; B Domeij-Nyberg
Journal:  J Chromatogr       Date:  1983-01-14
  6 in total
  15 in total

1.  Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine.

Authors:  U Hellgren; C M Kihamia; L F Mahikwano; A Björkman; O Eriksson; L Rombo
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 2.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 3.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

4.  On the question of interindividual variations in chloroquine concentrations.

Authors:  U Hellgren; G Alván; M Jerling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis.

Authors:  J C Wetsteyn; P J De Vries; B Oosterhuis; C J Van Boxtel
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

6.  Changing patterns of malaria in south-east Scotland: implications for practitioner awareness and prophylactic advice.

Authors:  L Willocks; M Jones; R Brettle; P Welsby; J Gray
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

Review 7.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

8.  Chloroquine in malaria. Isn't it time for revision of prophylaxis schedules?

Authors:  M Frisk; G Gunnert
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Authors:  Else M Bijker; Guido J H Bastiaens; Anne C Teirlinck; Geert-Jan van Gemert; Wouter Graumans; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Theo Arens; Karina Teelen; Wiebke Nahrendorf; Edmond J Remarque; Will Roeffen; Annemieke Jansens; Dunja Zimmerman; Martijn Vos; Ben C L van Schaijk; Jorien Wiersma; André J A M van der Ven; Quirijn de Mast; Lisette van Lieshout; Jaco J Verweij; Cornelus C Hermsen; Anja Scholzen; Robert W Sauerwein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-18       Impact factor: 11.205

10.  Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.

Authors:  J C Wetsteyn; A de Geus
Journal:  BMJ       Date:  1993-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.